Subthreshold amyloid predicts tau deposition in aging

Stephanie L. Leal, Samuel N. Lockhart, Anne Maass, Rachel K. Bell, William J. Jagust

Research output: Contribution to journalArticlepeer-review

97 Scopus citations


Current approaches to the early detection of Alzheimer’s disease (AD) rely upon classifying individuals as “positive” or “negative” for biomarkers related to the core pathology of β-amyloid (Aβ). However, the accumulation of Aβ begins slowly, years before biomarkers become abnormal. We used longitudinal [11C] Pittsburgh Compound B PET scanning and neuropsychological assessment to investigate the earliest changes in AD pathology and how it affects memory in cognitively normal older humans (N = 71; mean age 75 years; 35% male). We used [18F] AV-1451 PET scanning at the end of the observation period to measure subsequent tau deposition in a subset of our sample (N = 37). We found evidence for an inverted-U relationship between baseline Aβ levels and Aβ slope in asymptomatic older adults, suggesting a slowing of Aβ accumulation even in cognitively normal adults. In participants who were nominally amyloid negative, both the rate of amyloid accumulation and the baseline levels of Aβ predicted early tau deposition in cortical Braak regions associated with AD. Amyloid measures were only sensitive to memory decline as baseline levels of Aβ increased, suggesting that pathological accumulation occurs before impacting memory. These findings support the necessity of early intervention with amyloid-lowering therapies even in those who are amyloid negative.

Original languageEnglish (US)
Pages (from-to)4482-4489
Number of pages8
JournalJournal of Neuroscience
Issue number19
StatePublished - May 9 2018


  • Aging
  • Amyloid
  • Memory
  • PET
  • Preclinical
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Subthreshold amyloid predicts tau deposition in aging'. Together they form a unique fingerprint.

Cite this